Xylem (NYSE:XYL) Stock Moved Down to Neutral by JPMorgan Chase & Co.

Xylem (NYSE:XYL) was downgraded by equities researchers at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a report issued on Wednesday, Briefing.com reports. They currently have a $90.00 price target on the industrial products company’s stock. JPMorgan Chase & Co.‘s price target suggests a potential downside of 3.37% from the company’s previous close.

Other equities analysts have also issued research reports about the company. UBS Group decreased their target price on Xylem from $138.00 to $112.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. Mizuho decreased their target price on Xylem from $130.00 to $110.00 and set a “neutral” rating on the stock in a research note on Thursday, October 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Xylem in a research note on Wednesday, August 5th. Citigroup lowered their target price on shares of Xylem from $172.00 to $148.00 and set a “buy” rating for the company in a report on Monday, October 12th. Finally, Robert W. Baird raised their price target on Xylem from $163.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. Nine analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $136.38.

Xylem Trading Down 13.9%

XYL opened at $93.14 on Wednesday. The business’s 50-day moving average price is $106.50 and its 200-day moving average price is $118.31. Xylem has a 12 month low of $92.61 and a 12 month high of $154.27.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.37 EPS. On average, equities analysts forecast that Xylem will post 5.65 earnings per share for the current fiscal year.

Institutional Trading of Xylem

A number of institutional investors have recently added to or reduced their stakes in XYL. BlackRock Inc. acquired a new stake in shares of Xylem in the 2nd quarter worth approximately $2,959,730,000. State Street Corp raised its position in shares of Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the last quarter. XXEC Inc. purchased a new stake in Xylem in the 2nd quarter valued at approximately $850,841,000. Swedbank AB increased its position in Xylem by 0.3% during the first quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock worth $660,444,000 after buying an additional 18,759 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in Xylem by 1.1% in the 1st quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company’s stock valued at $569,207,000 after purchasing an additional 53,210 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Orders increased 10% year over year, suggesting underlying demand remains healthy despite near-term execution and project-timing issues. Adjusted earnings also rose from the prior-year period to $1.44 per share. Xylem Q3 2026 results
• Positive Sentiment: Management’s planned portfolio restructuring and cost actions could improve business focus and profitability over time, while infrastructure and data-center demand remain potential longer-term growth drivers.
• Neutral Sentiment: Management is preparing a portfolio reset and restructuring program. The effort may support future performance, but it could create transition costs and execution risk before benefits emerge. Xylem portfolio reset
• Negative Sentiment: Third-quarter revenue fell 3% year over year to $2.20 billion, below the approximately $2.28 billion consensus estimate. Earnings of $1.44 per share also missed estimates, reflecting weakness in metering and delayed or softer project activity. Xylem Q3 earnings miss
• Negative Sentiment: Xylem lowered its 2026 revenue and EPS outlook and issued weaker fourth-quarter expectations, signaling that customer pullbacks, project timing and metering pressure may persist. This guidance reduction was the main reason for the selloff. Xylem lowers 2026 outlook
• Negative Sentiment: The consensus price target was reduced by 10.52%, reinforcing concerns about weaker near-term earnings and valuation.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.